88 related articles for article (PubMed ID: 11370020)
1. Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis.
Glówka FK; Strzelecka D; Zapalski S
Chirality; 2001 Jun; 13(6):308-12. PubMed ID: 11370020
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man.
Główka FK
Chirality; 2000 Jan; 12(1):38-42. PubMed ID: 10602265
[TBL] [Abstract][Full Text] [Related]
3. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
4. LC procedure with SPE for quantification of indobufen enantiomers: pharmacokinetic studies.
Główka FK
J Pharm Biomed Anal; 2000 Feb; 22(1):93-100. PubMed ID: 10727127
[TBL] [Abstract][Full Text] [Related]
5. The dispositional enantioselectivity of indobufen in rat and mouse.
Strolin Benedetti M; Moro E; Frigerio E; Jannuzzo MG; Roncucci R; Caldwell J
Biochem Pharmacol; 1990 Oct; 40(8):1719-23. PubMed ID: 2242009
[TBL] [Abstract][Full Text] [Related]
6. The dispositional enantioselectivity of indobufen in man.
Strolm Benedetti M; Frigerio E; Tamassia V; Noseda G; Caldwell J
Biochem Pharmacol; 1992 May; 43(9):2032-4. PubMed ID: 1596290
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
8. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
Sidhu J; Priskorn M; Poulsen M; Segonzac A; Grollier G; Larsen F
Chirality; 1997; 9(7):686-92. PubMed ID: 9366029
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective pharmacokinetics of ornidazole after intravenous administration of individual enantiomers and the racemate.
Chen Y; Liu XQ; Zhong J; Zhao X; Wang Y; Wang G
Chirality; 2006 Nov; 18(10):799-802. PubMed ID: 16906493
[TBL] [Abstract][Full Text] [Related]
12. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis.
de Miranda Silva C; Fernandes BJ; Donadi EA; Silva LM; Coelho EB; Dantas M; Marques MP; Lanchote VL
J Clin Pharmacol; 2009 Aug; 49(8):965-72. PubMed ID: 19546252
[TBL] [Abstract][Full Text] [Related]
13. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of thiamylal enantiomers in humans.
Sueyasu M; Ikeda T; Taniyama T; Futugami K; Kataoka Y; Oishi R
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):128-32. PubMed ID: 9089003
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
[TBL] [Abstract][Full Text] [Related]
16. [RP-HPLC method for determination of protopine in plasma and pharmacokinetics in rats].
Yang DL; Huang XN; Sun AS; Huang B; Ye L; Shi JS
Yao Xue Xue Bao; 2001 Oct; 36(10):790-2. PubMed ID: 12579983
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics of tetrahydropalmatine after oral administration of (-)-enantiomer and the racemate.
Hong Z; Fan G; Chai Y; Yin X; Wu Y
Chirality; 2005 May; 17(5):293-6. PubMed ID: 15846827
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients.
Alshowaier IA; el-Yazigi A; Ezzat A; Abd el-Warith A; Nicholls PJ
J Clin Pharmacol; 1999 Nov; 39(11):1136-42. PubMed ID: 10579143
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective pharmacokinetics of diniconazole enantiomers in rabbits.
Wang Q; Qiu J; Zhou Z; Cao A; Wang X; Zhu W; Dang Z
Chirality; 2009 Jul; 21(7):699-703. PubMed ID: 18973222
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of beclobric acid enantiomers and their conjugates after single and multiple oral dosage of racemic beclobrate.
Mayer S; Spahn-Langguth H; Gikalov I; Mutschler E
Arzneimittelforschung; 1993 Jan; 43(1):40-3. PubMed ID: 8447845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
